SweetValueLab
Write for us

Welltower Inc. — Wall Street Analyst Estimates & Price Targets

WELL
NYSEReal EstateREIT - Healthcare FacilitiesCIK 0000766704welltower.comAbout WELL
Last close · Oct 16, 2026234.85+0.22 (+0.09%)
Market cap$169.2B

10 firms' latest targets, last 90 days: median $260.00 ($246.00–$275.00), 11% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$200$250NovJan 2026MarMayJulSep2025-10-17 · National Bank: $2462025-10-21 · Wells Fargo: $2002025-10-29 · Loop Capital Markets: $1962025-10-29 · UBS: $2032025-10-31 · Cantor Fitzgerald: $2002025-11-05 · Evercore ISI: $2082025-11-20 · Morgan Stanley: $2002025-11-25 · Wells Fargo: $2182025-12-04 · UBS: $2322025-12-15 · Jefferies: $2312026-01-05 · Cantor Fitzgerald: $2042026-01-08 · UBS: $2282026-02-12 · UBS: $2402026-02-12 · Cantor Fitzgerald: $2302026-02-18 · Morgan Stanley: $2152026-02-24 · RBC Capital: $2302026-02-24 · KeyBanc: $2402026-05-04 · BMO Capital: $2452026-05-04 · RBC Capital: $2382026-05-04 · UBS: $2492026-05-12 · Jefferies: $2482026-05-21 · Scotiabank: $2482026-05-22 · Mizuho Securities: $2392026-06-16 · Raymond James: $2262026-07-07 · Barclays: $2542026-07-08 · UBS: $2712026-07-22 · Mizuho Securities: $2602026-07-30 · Evercore ISI: $2602026-07-31 · Cantor Fitzgerald: $2602026-08-03 · RBC Capital: $2602026-08-04 · KeyBanc: $2752026-08-31 · Barclays: $2592026-09-01 · Morgan Stanley: $2512026-09-01 · Wells Fargo: $2662026-09-02 · Scotiabank: $2512026-09-15 · Jefferies: $2752026-09-21 · Evercore ISI: $2562026-10-13 · Barclays: $246
$200$250NovFebMayAug

Each firm's latest target

last 90 days · 10 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-13Barclays$246.00$259.00▼ 5%+7%+5%
2026-09-21Evercore ISI$256.00$260.00▼ 2%+10%+9%
2026-09-15Jefferies$275.00$248.00▲ 11%+17%+17%
2026-09-02Scotiabank$251.00$248.00▲ 1%+5%+7%
2026-09-01Morgan Stanley$251.00$215.00▲ 17%+6%+7%
2026-09-01Wells Fargo$266.00$218.00▲ 22%+13%+13%
2026-08-04KeyBanc$275.00$240.00▲ 15%+18%+17%
2026-08-03RBC Capital$260.00$238.00▲ 9%+11%+11%
2026-07-31Cantor Fitzgerald$260.00$230.00▲ 13%+11%+11%
2026-07-22Mizuho Securities$260.00$239.00▲ 9%+6%+11%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$4.8B+14%$0.66+120%est. $6.5B-27%est. $0.768
2024reported$6.0B+27%$1.57+138%est. $7.7B-22%est. $1.795
2025reported$8.5B+40%$1.39-11%est. $10.3B-18%est. $1.835
2026$14.2B+68%$2.86+57%$14.1B–$14.3B$2.85–$2.885
2027$16.3B+15%$3.25+14%$16.2B–$16.3B$3.13–$3.375
2028$18.1B+11%$3.96+22%$15.8B–$19.8B$2.74–$4.774
2029$18.8B+4%$5.44+37%$17.7B–$19.7B$5.04–$5.792
2030$30.0B+60%$5.80+7%$28.3B–$31.5B$5.38–$6.172
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.